title: Iron Replacement in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
abstract: BACKGROUND
  A number of controlled trials and prospective studies have compared intravenous (IV) to oral (PO) iron for the treatment of iron deficiency anemia with mixed results.
  
  
  METHODS
  We conducted a systematic review of trials published on 2014 that compared IV with PO iron to treat in patients with IBD. Meta-analysis was performed to generate effect estimates. Quality assessment was also performed according to GRADE criteria.
  
  
  RESULTS
  Five studies met our inclusion criteria, enrolling 694 patients. For the primary outcome of "response" (hemoglobin rise >2 g/dL), there was no significant difference between IV or PO iron; risk ratio for response with IV was 1.08 (95% CI, 0.9-1.2; P = 0.2). For the secondary outcome of mean change in hemoglobin (g/dL), the mean difference between PO and IV iron was not statistically significant (mean difference, 0.6 g/dL, 96% CI, -0.1 to 1.3; P = 0.08). IV iron was associated with a significantly greater initial rise in serum ferritin compared with PO iron (mean difference 89 ng/mL; 95% CI, 29-148, P = 0.003). There was a lower risk of withdrawal due to adverse events in these trials in the IV iron cohorts when compared with PO iron (risk ratio, 0.4; 95% CI, 0.1-1.0; P = 0.05).
  
  
  CONCLUSIONS
  We found no significant difference between IV and PO iron in correcting iron-deficiency anemia in patients with IBD in this meta-analysis. Patients who received IV iron had a greater rise in serum ferritin and were less likely to stop treatment due to adverse events, when compared with those who received PO iron.
authors.affiliation: Center for Inflammatory Bowel Disease, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
authors.forename: Anita
authors.initials: A
authors.lastname: Abhyankar
authors.forename: Alan C
authors.initials: AC
authors.lastname: Moss
mesh_terms: D000284:Administration, Oral; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D007275:Injections, Intravenous; D007501:Iron / Q000008:administration & dosage*; D011379:Prognosis; D011788:Quality of Life
chemical_list: D007501:Iron
references.citation: JAMA. 2000 Apr 19;283(15):2008-12
references.pmid: 10789670
references.citation: Stat Med. 2002 Jun 15;21(11):1539-58
references.pmid: 12111919
references.citation: Control Clin Trials. 1986 Sep;7(3):177-88
references.pmid: 3802833
references.citation: BMJ. 1997 Sep 13;315(7109):629-34
references.pmid: 9310563
references.citation: J Manag Care Pharm. 2005 Sep;11(7):565-74
references.pmid: 16137214
references.citation: Scand J Gastroenterol. 2005 Sep;40(9):1058-65
references.pmid: 16165718
references.citation: Am J Gastroenterol. 2005 Nov;100(11):2503-9
references.pmid: 16279906
references.citation: Inflamm Bowel Dis. 2006 Feb;12(2):123-30
references.pmid: 16432377
references.citation: Aliment Pharmacol Ther. 2006 Dec;24(11-12):1507-23
references.pmid: 17206940
references.citation: Inflamm Bowel Dis. 2007 Dec;13(12):1545-53
references.pmid: 17985376
references.citation: Am J Gastroenterol. 2008 May;103(5):1299-307
references.pmid: 18477354
references.citation: Am J Gastroenterol. 2008 May;103(5):1182-92
references.pmid: 18371137
references.citation: Am J Gastroenterol. 2009 Feb;104(2):465-83; quiz 464, 484
references.pmid: 19174807
references.citation: Inflamm Bowel Dis. 2009 Oct;15(10):1485-91
references.pmid: 19408339
references.citation: Scand J Gastroenterol. 2009;44(7):838-45
references.pmid: 19330567
references.citation: Inflamm Bowel Dis. 2010 Feb;16(2):275-9
references.pmid: 19575360
references.citation: Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524
references.pmid: 20068560
references.citation: Nat Rev Gastroenterol Hepatol. 2010 Nov;7(11):599-610
references.pmid: 20924367
references.citation: J Crohns Colitis. 2010 Feb;4(1):63-101
references.pmid: 21122490
references.citation: J Clin Epidemiol. 2011 Apr;64(4):401-6
references.pmid: 21208779
references.citation: J Clin Epidemiol. 2011 Apr;64(4):407-15
references.pmid: 21247734
references.citation: Gastroenterology. 2011 Sep;141(3):846-853.e1-2
references.pmid: 21699794
references.citation: J Crohns Colitis. 2012 Apr;6(3):267-75
references.pmid: 22405161
references.citation: Eur J Heart Fail. 2012 Apr;14(4):423-9
references.pmid: 22348897
references.citation: Am J Gastroenterol. 2013 Dec;108(12):1877-88
references.pmid: 24145678
references.citation: PLoS One. 2013;8(12):e75540
references.pmid: 24312441